NFE2L2 and diabetes mellitus: In this study, we found that Nrf2 was decreased, myocardial apoptosis was increased in diabetes rats, and Phase II enzyme inducer (CPDT) had ability of upregulating expression of Nrf2 and reducing myocardial apoptosis in DCM.